The pharmaceutical company BEIGENE (06160) has disclosed the granting of share-based awards to certain recipients.
On June 11, 2026, the board of directors, the compensation committee, and/or the chief executive officer, acting under their authority, granted options to six grantees, including two directors, pursuant to the terms of the 2016 Option and Incentive Plan. These options permit the purchase of a total of 94,068 American Depositary Shares.
Additionally, on the same date, the board, compensation committee, and/or CEO, acting under their authority and in accordance with the same plan, granted a total of 1,499,134 restricted share units to 8,555 grantees, which includes ten directors. Furthermore, performance share units were granted to 32 grantees, including one director. These performance units correspond to 161,039 American Depositary Shares upon 100% achievement of the performance target, with a maximum potential vesting of 322,078 ADSs if the target is 200% achieved.
The combined total of these restricted share units and performance share units is equivalent to 21,582,249 ordinary shares. This figure represents approximately 1.4% of the company's total issued share capital as of the date of the announcement.
Comments